Martin Baumgartner

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

Nature communications

Scientific reports

Communications biology

Cancers

University of Zürich Children's Hospital

Institut Pasteur (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Zürich Children's Hospital Aug 15 2011

Switzerland

Research Group Leader :: Oncology

University of Bern Feb 01 2008 - Jul 15 2011

Switzerland

Principal Investigator :: Vetsuisse Faculty

University of Zürich Jan 01 2005 - Jan 31 2008

Switzerland

seniro postdoc :: Medical Virology

University of California San Francisco May 01 2001 - Sep 30 2004

United States

Postdoc :: Cell and Tissue Biology

Education History

Institut Pasteur May 01 1997 - Mar 31 2001

France

PHD :: Immunologie

University of Bern

Switzerland

MSC :: Microbiology

Publications

Syeda Afshan, Yu Gang Kim, Jesse Mattsson, Malin Åkerfelt, Pirkko Härkönen, Martin Baumgartner, Matthias Nees
Targeting the cancer cells and cancer-associated fibroblasts with next-generation FGFR inhibitors in prostate cancer co-culture models. Cancer medicine 13 (18) (2024)
Michael Moret, Irene Pachón-Angona, Leandro Cotos, Shen Yan, Kenneth Atz, Cyrill Brunner, Martin Baumgartner, Francesca Grisoni, Gisbert Schneider
Leveraging molecular structure and bioactivity with chemical language models for de novo drug design. Nature communications 14 (1) (2023)
Michael Moret, Irene Pachón-Angona, Leandro Cotos, Shen Yan, Kenneth Atz, Cyrill Brunner, Martin Baumgartner, Francesca Grisoni, Gisbert Schneider
Leveraging molecular structure and bioactivity with chemical language models for de novo drug design. Nature communications 14 (1) (2023)
Michael Moret, Irene Pachón-Angona, Leandro Cotos, Shen Yan, Kenneth Atz, Cyrill Brunner, Martin Baumgartner, Francesca Grisoni, Gisbert Schneider
Leveraging molecular structure and bioactivity with chemical language models for de novo drug design. Nature communications 14 (1) (2023)
Michael Moret, Irene Pachón-Angona, Leandro Cotos, Shen Yan, Kenneth Atz, Cyrill Brunner, Martin Baumgartner, Francesca Grisoni, Gisbert Schneider
Leveraging molecular structure and bioactivity with chemical language models for de novo drug design. Nature communications 14 (1) (2023)
Jessica Migliavacca, Buket Züllig, Charles Capdeville, Michael A Grotzer, Martin Baumgartner
Author Correction: Cooperation of Striatin 3 and MAP4K4 promotes growth and tissue invasion. Communications biology 5 (1) (2022)
Karthiga Santhana Kumar, Cyrill Brunner, Matthias Schuster, Levi Luca Kopp, Alexandre Gries, Shen Yan, Simon Jurt, Kerstin Moehle, Dominique Bruns, Michael Grotzer, Oliver Zerbe, Gisbert Schneider, Martin Baumgartner
Discovery of a small molecule ligand of FRS2 that inhibits invasion and tumor growth. Cellular oncology (Dordrecht) (2022)
Jessica Migliavacca, Buket Züllig, Charles Capdeville, Michael A Grotzer, Martin Baumgartner
Cooperation of Striatin 3 and MAP4K4 promotes growth and tissue invasion. Communications biology 5 (1) (2022)
Charles Capdeville, Linda Russo, David Penton, Jessica Migliavacca, Milica Zecevic, Alexandre Gries, Stephan C F Neuhauss, Michael A Grotzer, Martin Baumgartner
Spatial proteomics finds CD155 and Endophilin-A1 as mediators of growth and invasion in medulloblastoma. Life science alliance 5 (6) (2022)
Anuja Neve, Jessica Migliavacca, Charles Capdeville, Marc Thomas Schönholzer, Alexandre Gries, Min Ma, Karthiga Santhana Kumar, Michael Grotzer, Martin Baumgartner
Crosstalk between SHH and FGFR Signaling Pathways Controls Tissue Invasion in Medulloblastoma. Cancers 11 (12) (2019)
Anuja Neve, Karthiga Santhana Kumar, Dimitra Tripolitsioti, Michael A Grotzer, Martin Baumgartner
Publisher Correction: Investigation of brain tissue infiltration by medulloblastoma cells in an ex vivo model. Scientific reports 8 (1) (2018)
Anuja Neve, Karthiga Santhana Kumar, Dimitra Tripolitsioti, Michael A Grotzer, Martin Baumgartner
Investigation of brain tissue infiltration by medulloblastoma cells in an ex vivo model. Scientific reports 7 (1) (2017)

Martin Baumgartner.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Martin Baumgartner